{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T10:36:20Z","timestamp":1790937380398,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.ygyno.2011.02.012","type":"journal-article","created":{"date-parts":[[2011,3,16]],"date-time":"2011-03-16T04:16:52Z","timestamp":1300249012000},"page":"472-476","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"title":["Radical fimbriectomy: A reasonable temporary risk-reducing surgery for selected women with a germ line mutation of BRCA 1 or 2 genes? Rationale and preliminary development"],"prefix":"10.1016","volume":"121","author":[{"given":"Eric","family":"Leblanc","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice","family":"Narducci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Farre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Philippe","family":"Peyrat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Taieb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claude","family":"Adenis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Vennin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2011.02.012_bb0005","doi-asserted-by":"crossref","first-page":"177","DOI":"10.6004\/jnccn.2006.0017","article-title":"Bilateral risk-reducing oophorectomy in BRCA1 and BRCA2 mutation carriers","volume":"4","author":"Domchek","year":"2006","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.ygyno.2011.02.012_bb0010","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.humpath.2005.06.006","article-title":"Hereditary ovarian cancer","volume":"36","author":"Prat","year":"2005","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ygyno.2011.02.012_bb0015","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/ijc.24038","article-title":"Time to stop ovarian cancer screening in BRCA1\/2 mutation carriers?","volume":"124","author":"van der Velde","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ygyno.2011.02.012_bb0020","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1200\/JCO.2007.13.9626","article-title":"Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study","volume":"26","author":"Kauff","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2011.02.012_bb0025","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/jnci\/djn442","article-title":"Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers","volume":"101","author":"Rebbeck","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ygyno.2011.02.012_bb0030","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1001\/jama.2010.1237","article-title":"Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality","volume":"304","author":"Domchek","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.ygyno.2011.02.012_bb0035","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ygyno.2005.06.065","article-title":"Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers","volume":"100","author":"Finch","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2011.02.012_bb0040","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/modpathol.2009.64","article-title":"Intercepting early pelvic serous carcinoma by routine pathological examination of the fimbria","volume":"22","author":"Semmel","year":"2009","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ygyno.2011.02.012_bb0045","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/00006250-200801000-00039","article-title":"ACOG Practice Bulletin No. 89. Elective and risk-reducing salpingo-oophorectomy","volume":"111","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2011.02.012_bb0050","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/jncimonographs\/lgi012","article-title":"Reproductive issues for women with BRCA mutations","author":"Friedman","year":"2005","journal-title":"J Natl Cancer Inst Monogr"},{"key":"10.1016\/j.ygyno.2011.02.012_bb0055","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/IGC.0b013e3181a83cd5","article-title":"Fatigue and quality of life after risk-reducing salpingo-oophorectomy in women at increased risk for hereditary breast-ovarian cancer","volume":"19","author":"Michelsen","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ygyno.2011.02.012_bb0060","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1080\/13697130902780846","article-title":"Climacteric symptoms in women undergoing risk-reducing bilateral salpingo-oophorectomy","volume":"12","author":"Benshushan","year":"2009","journal-title":"Climacteric"},{"key":"10.1016\/j.ygyno.2011.02.012_bb0065","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0090-8258(03)00072-6","article-title":"Quality of life in women at risk for ovarian cancer who have undergone risk-reducing oophorectomy","volume":"89","author":"Robson","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2011.02.012_bb0070","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/gme.0b013e31818888f7","article-title":"Increased cardiovascular mortality after early bilateral oophorectomy","volume":"16","author":"Rivera","year":"2009","journal-title":"Menopause"},{"key":"10.1016\/j.ygyno.2011.02.012_bb0075","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1097\/gme.0b013e318174f155","article-title":"Long-term risk of depressive and anxiety symptoms after early bilateral oophorectomy","volume":"15","author":"Rocca","year":"2008","journal-title":"Menopause"},{"key":"10.1016\/j.ygyno.2011.02.012_bb0080","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1097\/AOG.0b013e3181a11c64","article-title":"Ovarian conservation at the time of hysterectomy and long-term health outcomes in the nurses' health study","volume":"113","author":"Parker","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2011.02.012_bb0085","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ygyno.2009.12.023","article-title":"Does risk-reducing bilateral salpingo-oophorectomy leaved behind residual tube?","volume":"117","author":"Cass","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2011.02.012_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.pap.0000201826.46978.e5","article-title":"Advances in the recognition of tubal intraepithelial carcinoma: applications to cancer screening and the pathogenesis of ovarian cancer","volume":"13","author":"Lee","year":"2006","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.ygyno.2011.02.012_bb0095","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/01.pas.0000180854.28831.77","article-title":"The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome","volume":"30","author":"Medeiros","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ygyno.2011.02.012_bb0100","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3121\/cmr.2007.702","article-title":"Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer","volume":"5","author":"Crum","year":"2007","journal-title":"Clin Med Res"},{"key":"10.1016\/j.ygyno.2011.02.012_bb0105","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/PAS.0b013e31817d74a7","article-title":"Transitional cell metaplasia of fallopian tube fimbriae: a potential mimic of early tubal carcinoma in risk reduction salpingo-oophorectomies from women With BRCA mutations","volume":"33","author":"Rabban","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ygyno.2011.02.012_bb0110","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ygyno.2009.01.013","article-title":"Precursors to pelvic serous carcinoma and their clinical implications","volume":"113","author":"Folkins","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2011.02.012_bb0115","article-title":"Tubal ligation and the risk of ovarian cancer: review and meta-analysis","author":"Cibula","year":"2010","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ygyno.2011.02.012_bb0120","article-title":"The fallopian tube\u2013peritoneal junction: a potential site of carcinogenesis","author":"Seidman","year":"2010","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.ygyno.2011.02.012_bb0125","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/PAS.0b013e3181cf3d79","article-title":"The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory","volume":"34","author":"Kurman","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ygyno.2011.02.012_bb0130","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nrc2946","article-title":"The genesis and evolution of high-grade serous ovarian cancer","volume":"10","author":"Botwell","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ygyno.2011.02.012_bb0135","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1097\/00000478-200110000-00009","article-title":"Occult carcinoma in prophylactic oophorectomy specimens: prevalence and association with BRCA germline mutation status","volume":"25","author":"Colgan","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ygyno.2011.02.012_bb0140","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1006\/gyno.2000.6071","article-title":"Occult cancer of the fallopian tube in BRCA-1 germline mutation carriers at prophylactic oophorectomy: a case for recommending hysterectomy at surgical prophylaxis","volume":"80","author":"Paley","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2011.02.012_bb0145","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1097\/PAS.0b013e3181bc6059","article-title":"Multistep level sections to detect occult fallopian tube carcinoma in risk-reducing salpingo-oophorectomies from women with BRCA mutations: implications for defining an optimal specimen dissection protocol","volume":"33","author":"Rabban","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ygyno.2011.02.012_bb0150","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/path.2091","article-title":"A candidate precursor to serous carcinoma that originates in the distal fallopian tube","volume":"211","author":"Lee","year":"2007","journal-title":"J Pathol"},{"key":"10.1016\/j.ygyno.2011.02.012_bb0155","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1200\/JCO.2008.16.4814","article-title":"Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention","volume":"26","author":"Carlson","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2011.02.012_bb0160","article-title":"\u201cPrimary peritoneal\u201d high-grade serous carcinoma is very likely metastatic from serous tubal intraepithelial carcinoma: assessing the new paradigm of ovarian and pelvic serous carcinogenesis and its implications for screening for ovarian cancer","author":"Seidman","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2011.02.012_bb0165","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/PAS.0b013e3181868904","article-title":"Serous tubal intraepithelial carcinoma and the dominant ovarian mass: clues to serous tumor origin?","volume":"33","author":"Roh","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ygyno.2011.02.012_bb0170","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/PAS.0b013e3181dcede7","article-title":"Shortened telomeres in serous tubal intraepithelial carcinoma: an early event in ovarian high-grade serous carcinogenesis","volume":"34","author":"Kuhn","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ygyno.2011.02.012_bb0175","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/PGP.0b013e3181f45f3e","article-title":"The origin of ovarian carcinoma: a unifying hyppothesis","volume":"30","author":"Auersperg","year":"2010","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.ygyno.2011.02.012_bb0180","article-title":"Does bilateral salpingectomy with ovarian retention warrant consideration as a temporary bridge to risk-reducing bilateral oophorectomy in BRCA1\/2 mutation carriers?","author":"Greene","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2011.02.012_bb0185","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1470-2045(09)70026-9","article-title":"Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)","volume":"10","author":"Menon","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ygyno.2011.02.012_bb0190","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1200\/JCO.2006.09.1066","article-title":"Meta-analysis of BRCA1 and BRCA2 penetrance","volume":"25","author":"Chen","year":"2007","journal-title":"J Clin Oncol"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825811001247?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825811001247?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:27:46Z","timestamp":1758770866000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825811001247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0090825811001247"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2011.02.012","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radical fimbriectomy: A reasonable temporary risk-reducing surgery for selected women with a germ line mutation of BRCA 1 or 2 genes? Rationale and preliminary development","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2011.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}